News
09-11-2011, 09:40 PM
Nektar Therapeutics announced today that positive results from the company's Phase 2 clinical study of NKTR-102 in patients with metastatic breast cancer were presented at the ASCO 2011 Breast Cancer Symposium in San Francisco, California.
More... (http://www.news-medical.net/news/20110912/Nektar-announces-positive-results-from-NKTR-102-Phase-2-study-on-metastatic-breast-cancer.aspx)
More... (http://www.news-medical.net/news/20110912/Nektar-announces-positive-results-from-NKTR-102-Phase-2-study-on-metastatic-breast-cancer.aspx)